Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nouscom AG

www.nouscom.com

Latest From Nouscom AG

Appointments: Personnel Changes At Horama, ISA Pharma, Calidi, Protagonist, Curis And Nouscom

This week's announcements include a new chairman at Horama and new CEOs at ISA Pharmaceuticals and Calidi Biotherapeutics, a new chief development officer at Protagonist Therapeutics, a new R&D head at Curis, and a new chief medical officer at Nouscom.

Appointments Leadership

NousCom CEO Outlines Cancer Vaccine Strategy

NousCom CEO and co-founder Alfredo Nicosia speaks to Scrip senior editor Lucie Ellis during BIO-Europe, a partnering meeting held in berlin Nov. 6-8, about the company's recent series B financing.

Business Strategies Cancer

Venture Funding Deals: Semma, Arcus Raise $100m-Plus For Cancer, Diabetes Therapies

Semma's $114m Series B round and a $107m Series C for Arcus top November's list of biopharmaceutical venture capital deals. Forty Seven, Medeor and Tricida also closed sizeable rounds.

StartUps and SMEs Financing

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Five funds raised more than $1bn to back biotech firms; Arcus leads recent VC rounds with $107m GV-backed Series C; Celgene, Valeant sell notes to retire debt; and Alnylam cashes in on investor goodwill.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Nouscom AG
  • Senior Management
  • Alfredo Nicosia, PhD, CEO
    Elisa Scarselli, MD, CSO
    Stefano Colloca, MD, CTO
    Marina Udier, PhD, COO
  • Contact Info
  • Nouscom AG
    Phone: 61 201 18 31
    Baumleingasse 18
    Basel, CH-4051
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register